Patents for A61P 27 - Drugs for disorders of the senses (53,017)
04/1998
04/22/1998CN1179774A Arginine analogues having nitric oxide synthase inhibitor activity
04/22/1998CN1179725A Modulation of cell proliferation and wound healing
04/22/1998CN1179418A Novel cyloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
04/22/1998CN1179316A External use medicine for treating myopia
04/21/1998US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
04/21/1998US5741810 Prostaglandins for ocular hypotension for treatment of glaucoma
04/21/1998US5741809 Compounds and methods for the treatment of cardiovascular inflammatory and immune disorders
04/21/1998US5741788 Heterocyclic compounds and their preparation and use
04/21/1998US5741692 Used in compositions for selectively and completely disinserting vitreous body from neural retina of an eye
04/15/1998EP0835937A2 Human MYT-1 kinase clone
04/15/1998EP0835936A2 Arginyl tRNA synthase
04/15/1998EP0835313A1 Omp26 antigen from haemophilus influenzae
04/15/1998EP0835263A2 Somatostatin peptides
04/15/1998EP0835128A1 Use of il-11 to treat inflammation
04/15/1998EP0835110A1 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
04/15/1998EP0797442A4 Treatment of optic neuritis
04/15/1998CN1178799A Method for extracting solomonscal polyose from Chinese drug solomonseal rhizome
04/15/1998CN1178683A Eyesight improving liquid for curing shortsightedness by fumigation
04/15/1998CN1178682A Chinese drug Mingmudan pill for improving eyesight and its producing method
04/14/1998US5739351 Neurokinin a antagonists
04/14/1998US5739338 Skin disorders, antiinflammatory agents, antitumor agents, vision defects, viricides, immunosuppressants
04/14/1998US5739165 Reducing sugar-free mixture of ibuprofen and phenylpropanolamine; heat and storage stability, discoloration inhibition
04/14/1998US5739148 6-(2-Imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
04/14/1998US5739115 Sulfated maltooligosaccharides with heparin-like properties
04/14/1998US5739102 Wound healing
04/14/1998CA2123367C Anti-allergic pharmaceutical composition for ophthalmic topical administration
04/09/1998WO1998014189A1 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
04/09/1998DE19637518A1 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung PTX-sensitive G-proteins, their production and use
04/09/1998CA2267248A1 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
04/08/1998EP0834510A2 Flavone derivative and medicine comprising the same
04/08/1998EP0834508A1 Substituted biphenyl or phenylpyridine derivatives, process for their preparation and pharmaceutical compositions containing them
04/08/1998EP0834315A1 Use of an imidazole derivative for the manufacture of a medicament for preventing and/or treating rhinitis
04/08/1998EP0834310A1 Use of adamantin-derivatives for the treatment of internal-ear-diseases
04/08/1998EP0833892A1 Human hepatoma-derived growth factor-2
04/08/1998EP0833665A1 Compositions containing nucleic acids and ligands for therapeutic treatment
04/08/1998EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations
04/08/1998EP0833632A1 Method to increase retinal blood flow
04/08/1998EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
04/08/1998EP0562006B1 Homo-prostaglandin derivatives as ocular hypotensives
04/08/1998CN1178533A Process for isolating galanthamine
04/07/1998US5736578 Treatment of sleep disorders
04/07/1998US5736533 Inhibiting colonization of streptococcus pneumoniae, hemophilus influenza or parainfluenza, burkholderia (pseudomonas) cepacia by administering binding inhibiting oligosaccharide
04/07/1998US5736516 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein protein
04/07/1998US5736149 Allergenic proteins and peptides from johnson grass pollen
04/02/1998WO1998013369A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists
04/02/1998WO1998013366A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
04/02/1998WO1998013354A1 Quinazoline derivatives and pharmaceutical compositions containing them
04/02/1998WO1998013071A1 Gene therapy for inhibition of angiogenesis
04/02/1998WO1998013031A2 Medicinal aerosol formulations comprising budesonide
04/02/1998CA2266431A1 Medicinal aerosol formulations comprising budesonide
04/02/1998CA2266419A1 Gene therapy for inhibition of angiogenesis
04/02/1998CA2265950A1 Spiro-azacyclic derivatives and their use as therapeutic agents
04/01/1998EP0832198A1 Oxygen activatable formulations for disinfection or sterilization
04/01/1998EP0832081A1 Bicyclic-aromatic compounds
04/01/1998EP0832076A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
04/01/1998EP0832061A1 Benzamide derivatives and their use as vasopressin antagonists
04/01/1998EP0831903A1 Connective tissue growth factor
04/01/1998EP0831885A1 Methods and uses of connective tissue growth factor as an induction agent
04/01/1998EP0831868A1 Ocular therapy in sjögren's syndrome using topically applied androgens or tgf-beta
04/01/1998EP0831854A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
04/01/1998EP0831802A1 Treatment of a trabecular meshwork whose cells are subject ot inhibition of cell division with non-steroidal anti-inflammatory drugs
04/01/1998EP0831801A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork
04/01/1998EP0831798A1 Use of selegiline to treat hearing loss in mammals
04/01/1998EP0831797A1 Pharmaceutically active carotenoids
04/01/1998EP0561913B1 Use of pyridine derivatives in the treatment of ocular hypertension
04/01/1998CN1177927A Extracts of shark cartilage, process of production and uses thereof
04/01/1998CN1177492A Medicine for preventing and treating eye diseases
03/1998
03/31/1998US5733929 Pharmaceutical composition for treating or preventing allergic rhinitis
03/31/1998US5733923 Secretory pancreatic phospholipase a2
03/31/1998US5733901 Administering to treat skin and respiratory system disorders, inflammatory disorders of the bowel, and allergic rhinitis/conjunctivitis
03/31/1998US5733876 Method of inhibiting angiogenesis
03/31/1998US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
03/26/1998WO1998012221A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
03/26/1998WO1998012211A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
03/26/1998WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998WO1998012176A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/26/1998WO1998011915A1 Strain selection of pneumococcal surface proteins
03/26/1998WO1998011875A1 Method and composition for rewetting contact lenses and relieving eye dryness
03/26/1998WO1998011874A1 Pharmaceutical composition forming a gel
03/26/1998WO1998005338A3 Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
03/26/1998WO1997043272A3 Benzofurans and benzopyrans as chronobiological agents
03/26/1998CA2267343A1 Strain selection of pneumococcal surface proteins
03/26/1998CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998CA2266639A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/25/1998EP0830347A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
03/24/1998US5731319 Antiallergens; antihistamines
03/24/1998US5731294 Inhibition of neovasularization using VEGF-specific oligonucleotides
03/24/1998US5731293 Enzyme inhibitors
03/24/1998US5730998 Administering substance p antagonist
03/24/1998CA2129037C Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
03/24/1998CA1339770C Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
03/19/1998WO1998011212A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998WO1998011089A1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors
03/19/1998WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998WO1998010652A1 NOVEL trpS
03/19/1998CA2265467A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/18/1998EP0828732A1 Peptidyl compounds and their therapeutic use
03/18/1998EP0828730A1 Piperazine derivatives
03/18/1998EP0828491A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects